Giovanna Zambruno

Title: Giovanna Zambruno: Innovator in Proangiogenic Peptide Research

Introduction

Giovanna Zambruno is a notable inventor based in Rome, Italy. She has made significant contributions to the field of pharmacology through her innovative research on peptides. Her work focuses on the development of agents that promote angiogenesis, which is crucial for various medical applications.

Latest Patents

Zambruno holds a patent for a peptide derived from vascular endothelial growth factor receptor-1 binding integrin α5β1, which exhibits proangiogenic activity. This patent describes a sequence peptide isolated in the domain II type-immunoglobulin (Type-Ig) of the Vascular Endothelial Growth Factor receptor 1 (VEGF-1). The peptide is usable for the preparation of pharmacological agents that have proangiogenic activity.

Career Highlights

Throughout her career, Zambruno has worked with esteemed institutions such as the Consiglio Nazionale Delle Ricerche and the Università Degli Studi Di Roma "La Sapienza". Her research has contributed to advancements in understanding the mechanisms of angiogenesis and its implications in medicine.

Collaborations

Zambruno has collaborated with notable colleagues, including Simonetta Soro and Veronica Morea. These partnerships have enhanced her research and expanded the impact of her work in the scientific community.

Conclusion

Giovanna Zambruno's innovative research and patent in proangiogenic peptides highlight her significant role in advancing pharmacological science. Her contributions continue to influence the development of new therapeutic agents.